A, non-B hepatitis did not convey the seriousness of the Hepatitis C problem for health care workers exposed to needlestick injuries (June 1999, 47[6] , [237] [238] [239] [240] [241] [242] [243] [244] .
It is difficult to understand the resistance of health care worker unions (e.g., OSHA, NIOSH, CDC) to explore all possible means to prevent transmission of bloodborne pathogens via needlestick injuries. It is less difficult to understand the support of large needle manufacturers who support legislative mandates to use their costly new products
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TO THE EDITOR which mayor may not solve the problem. All of the regulatory agencies and manufacturers have been aware of a less costly alternative for years. My concern for this problem was heightened in the early 1980s when our hospital became the primary treatment center for a large population of southeast Asians who migrated to our area with a large reservoir of Hepatitis-B carriers. We experienced several instances of Hepatitis transmission due to needlestick injury. Unfortunately, as Porta, Handelman, and McGovern's article points out, the importance of delayed transmission of Hepatitis C for health care workers (HCW) was not appreciated.
We used every means available then to protect our employees from Hepatitis-B exposure before we had an effective vaccine.
Although the precise number of needlestick injuries is not known, OSHNNIOSH suggests there are about 800,000 needlestick injuries per year. This number seems fairly constant despite 16 years of OSHA guidelines and standards. We surveyed our employees and learned that despite our re-enforcement of the regulations this did not change the reflex behavior of our nurses to recap used needles. Larger studies also seem to confirm this reflex tendency. Our prevention program recognized this behavior and we developed a product which made recapping safe.
It was difficult to test this concept in an environment where the Very, very easy to use. The~Lens
Letters continued from page 201 standard cautioned against recapping. We conducted studies using a safe recapping device at our hospital and a large southern facility. There were no needlestick injuries using our device. A similar concept used in New Zealand also reported success in preventing needlestick injuries. We shared that experience with all of the regulatory agencies, needle manufacturers, and HCW unions and offered to participate in a joint evaluation of this concept.
It has been reported that 20% to 30% of needlestick injuries are a result of recapping which suggests 70% to 80% of injuries are due to uncapped needles. Capped needles do not cause injury. Despite the various pressures, the health care industry remains resistant to change opinions which could increase the cost fourfold. A simple, cost effective alternative might mitigate the need for more regulations or mandates.
The article highlights the real risk of these injuries and emphasizes the need for an effective vaccine for Hepatitis-C and mv. When a vaccine is found, needlestick injuries will become a nuisance and not a life altering experience. (47[12] , 574-583). As a corporate nurse for a large company, I have been involved in the integration and evolution of a large health and safety management system. During our development phase, many lessons were learned and dollars spent.
I was impressed by how our experience validated the recommendations in Ms. Amann's article. As someone who has experienced the challenges of building such a system, the direction and guidance articulated in the article are right on target. The multifaceted information now provided by our system has become critical to managing our worldwide Occupational Health program. This is a valuable information for occupational health nurses who need to implement and maintain a database system for their company.
Karen G . Griffith, MBA, BSN, RN Chandler, AZ
LATEX ALLERGY
To the Editor:
I am writing to say thank you for printing the article "Latex Allergy in Health Care Workers; What are the Risks?" by Colleen Karvonen (November 1999,47[11] ,519-525).
As an RN, and severe latex aller-gy sufferer, I was pleased to see this article. It was extremely well written and frctually accurate. I have seen an increase of latex allergy To the Editor:
In the January 2000 issue, the article "Ergonomics: CTD Management Evaluation Tool" (48[1], 17-24) described a tool that may be used by either occupational health nurses or other occupational health and safety professionals in several ways. It can be used not only in program establishment and evaluation, but also as an instrument that can generate valuable research data.
If readers would like to receive a copy of the tool they may contact me by phone at (919) 966-2597 or email at judy_ostendorf@unc.edu.
Thank you for the opportunity to provide readers with this service.
Judith S. 
